Current Assets
Trading Securities in Marketable Securities
Medtronic Trading Securities in Marketable Securities increased by 8.8% to $730.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 9.8%, from $809.00M to $730.00M.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2024
Last reportedQ3 2026Feb 24, 2026
Metric ID:
trading_securities_in_marketable_securitiesHistorical Data
6 periods
| Q4 '24 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|
| Value | $859.00M | $809.00M | $705.00M | $697.00M | $671.00M | $730.00M |
| QoQ Change | — | -5.8% | -12.9% | -1.1% | -3.7% | +8.8% |
| YoY Change | — | — | -17.9% | — | — | -9.8% |
Range$671.00M – $859.00M
CAGR-12.2%
Avg YoY Growth-13.8%
Median YoY Growth-13.8%
Trading Securities in Marketable Securities at Other Companies
Frequently Asked Questions
- What is Medtronic's trading securities in marketable securities?
- Medtronic (MDT) reported trading securities in marketable securities of $730.00M in Q4 2025.
- How has Medtronic's trading securities in marketable securities changed year-over-year?
- Medtronic's trading securities in marketable securities decreased by 9.8% year-over-year, from $809.00M to $730.00M.